According to the Centers for Disease Control and Prevention (CDC), between 300,000 and 600,000 people in the United States are affected by DVT or pulmonary embolism (PE) each year.
Studies in recent years have clarified the risk of venous thromboembolism (VTE) associated with air and automobile travel. While its nickname with the general public, “Economy-Class Syndrome”, may sound fairly benign, VTE can result in serious injury or death.
A remarkable new portable vascular compression system weighs only one pound and offers a 17-hour battery life.
Christine Wunderlin recently told her story to the Las Vegas Review-Journal. She said that when she underwent a mastectomy during her fight with breast cancer, she also lost the lymph nodes under one arm. As a result, Wunderlin soon suffered from lymphedema, which caused her left arm to swell to twice its normal size. Greg Grambor, president of Vascular PRN, a distributor of pneumatic compression equipment, says Wunderlin's case is not uncommon.
A recent study supports theories that rheumatoid arthritis increases the risk of blood clots in the veins, a potentially hazardous, but manageable, condition.
A recent report shows that compression therapy can significantly reduce the cost of treating venous leg ulcers.
New research shows that inexpensive leg compression devices help prevent fatal blood clots in stroke patients.
Vascular PRN, a leading national distributor of pneumatic compression therapy equipment, now carries arterial compression systems.
Vascular PRN, a leading national distributor of pneumatic compression therapy equipment, is now offering solutions for healthcare professionals struggling to fit extra large patients with compression garments.
The drug manufacturer Bayer has paid millions of dollars to settle lawsuits involving pulmonary embolism or deep vein thrombosis (DVT). The lawsuits were filed by women who used the company's Yaz or Yasmin birth control pills and subsequently developed blood clots.